HAPPE Spine has revealed that Andrew Iott, who has more than 20 years of experience in medical device product development and commercialisation, with extensive knowledge of the spine market, has accepted an offer to become the company’s president and CEO.
According to a recent press release, as a co-founder of Globus Medical, Iott played a critical role in taking the company from a startup to a worldwide leader in orthopaedics.
Ryan Roeder, founder and CTO of HAPPE Spine, commented: “The fact that HAPPE has landed an experienced executive like Andrew Iott clearly speaks volumes for our value proposition.”
The HAPPE (HydroxyApatite Porous PolyEtheretherketone) material platform offers interconnected, cancellous porosity with exposed hydroxyapatite on pore surfaces to enable robust bone in-growth and on-growth confirmed in preclinical testing, states the company.
“I am very excited to join the HAPPE Spine management team and continue the development of this innovative platform,” said Iott. “The superior bone healing environment afforded by optimum biomechanical properties and a porous microstructure, that is fully integrated with hydroxyapatite, is a clear advancement in orthopaedics.”
HAPPE Spine is preparing to enter the market with the INTEGRATE-C, a cervical interbody spinal fusion cage.
“I’m convinced that the spine and broader orthopaedic industry are looking for implants that make a leap forward in material science to provide an enhanced platform for osteointegration and HAPPE is that material. I am looking forward to working with this team to launch market disrupting products,” added Iott.
